Experts′ consensus on severe acute respiratory syndrome coronavirus-2 vaccination of children
- VernacularTitle:儿童新型冠状病毒疫苗接种专家共识
- Author:
Yuejie ZHENG
1
;
Xiaochuan WANG
;
Luzhao FENG
;
Zhengde XIE
;
Yi JIANG
;
Gen LU
;
Xingwang LI
;
Rongmeng JIANG
;
Jikui DENG
;
Miao LIU
;
Baoping XU
;
Zhuang WEI
;
Gang LIU
;
Xiaoxia LU
;
Runming JIN
;
Zhisheng LIU
;
Yunxiao SHANG
;
Sainan SHU
;
Yan BAI
;
Min LU
;
Guanghua LIU
;
Wanjun LUO
;
Yuxia CUI
;
Leping YE
;
Likai LIN
;
Dongchi ZHAO
;
Adong SHEN
;
Jianbo SHAO
;
Lijuan XIONG
;
Liwei GAO
;
Tianyou WANG
;
Zhengyan ZHAO
;
Yonghong YANG
;
Kunling SHEN
Author Information
- Keywords: Severe acute respiratory syndrome coronavirus-2; Child; Vaccination; Adverse reaction
- From: Chinese Journal of Applied Clinical Pediatrics 2021;36(18):1361-1367
- CountryChina
- Language:Chinese
- Abstract: At present, severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is still rampant worldwide.As of September 10, 2021, there were about 222 million confirmed cases of corona virus disease 2019(COVID-19)and more than 4.6 million deaths worldwide.With the development of COVID-19 vaccines and the gradual vaccination worldwide, the increasing number of cases in children and unvaccinated young people has drawn attention.According to World Health Organization surveillance data, the proportion of COVID-19 infection cases in children gradually increased, and the proportion of cases in the age groups of under 5 years and 5-14 years increased from 1.0% and 2.5% in January 2020 to 2.0% and 8.7% in July 2021, respectively.At present, billions of adults have been vaccinated with various COVID-19 vaccines worldwide, and their protective effects including reducing infection and transmission, reducing severe disease and hospitalization, and reducing death, as well as high safety have been confirmed.Canada, the United States, Europe and other countries have approved the emergency COVID-19 vaccination in children and adolescents aged 12 to 17 years, and China has also approved the phased vaccination of COVID-19 vaccination in children and adolescents aged 3 to 17 years. For smooth advancement and implementation of COVID-19 vaccination in children, academic institutions, including National Clinical Research Center for Respiratory Diseases, National Center for Children′s Health, and The Society of Pediatrics, Chinese Medical Association organized relevant experts to reach this consensus on COVID-19 vaccination in children.
